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Aim. Study was designed to assess relationship between aortic compliance and homogeneity of heart electrical activity in dialysis
patients. Methods. Study group was consisted of 120 dialyzed patients; 57 (age 50,7 ± 7,1) were on continuous ambulatory
peritoneal dialysis (CAPD) and 73 (age 51,6 ± 7,6) were hemodialyzed (HD). Three-dimensional vectorocardiographic (VCG)
monitoring was done to assess: QRS-Tangle, Tel and Taz. Echocardiography was performed to assess: Aomax,A o min,A S I( a o r t i c
siﬀness index). Results. ASI in HD as well as in CAPD patients was signiﬁcantly higher compared to controls [resp., 5,51 (±1,32),
5,83 (±1,41), 3,07 (±1,09)]. Cut-oﬀ value of ASI was 5,67. In HD patients strong correlations between ASI and QRS-Tangle, Tel
and Taz were determined (resp., r = 0,429, P<0,001; r = 0,432, P ≤ 0,001 and r = 0,387, P = 0,001). In CAPD group were
signiﬁcant association between ASI and QRS-Tangle, Tel and Taz (resp., r = 0,452, P<0,001; r = 0,417, P<0,001 and r = 0,390,
P = 0,001). ASI was independently and markedly associated with: QRS-Tangle, Telev, Taz, ADMA, cTnT, CRP, Total-chol, LDL-chol
in HD and CAPD patients. Conclusions. ASI and VCG indices are higher in HD and CAPD patients. Correlation between ASI and
VCG parameters may reﬂect unfavourable inﬂuence of poor aortic compliance on the electrical activity of the heart in dialyzed
patients. Hypertrophy aggravates repolarization disturbances in hemodialyzed patients.
1.Introduction
Atherosclerosis is common in patients with chronic renal
failure and renal dysfunction and a recognized risk factor
for cardiovascular disease. Atherosclerosis is regarded as a
combination of two major separate diseases: atherosis and
sclerosis. Aortic stiﬀness reﬂects sclerotic component and
means mechanical properties of aortic wall. Renal failure
particularly unfavorably aﬀects the elastic properties of the
aorta. This inﬂuence is carried out both by intensifying
the classic risk factors for atherosclerosis and what is even
more important due to adverse hemodynamic eﬀects and
metabolic toxins on the aortic wall. It is well known that
aortic stiﬀness is an independent predictor of all-cause and
cardiovascular mortality in diﬀerent group of patients [1]
including patients who require haemodialysis [2]. The
stiﬀness of the aorta inﬂuences aortic conduit function and
causes pressure elevation and abnormal pressure pattern that
increases the afterload of the left ventricle. In that way, it may
induce left ventricle hypertrophy and alter on left ventricle
diastolic and systolic function.
Hyperthrophic left ventricle is particularly vulnerable to
ischemiaandthesetwoconditionscanincreaseheterogeneity
of electric activity of the heart. Depolarization disturbances
reﬂect ventricular structural abnormalities, whereas repo-
larization disturbances represent heterogeneities associated2 The Scientiﬁc World Journal
with electrical instability and sudden cardiac death [3]. Stan-
dard ECG has limited usefulness to predict cardiac events.
The more reliable method for the quantiﬁcation of
ventricular depolarization and repolarization is vectorocar-
diography. It is a method of recording and measuring the
changes in value and direction of forces of electromotoric
heart during its cycle, expressed as a function of the vector
at the time [4]. Developing techniques for automatically
transforming computing ECG, VCG has opened the way
to conduct extensive research on the usefulness of VCG
various parameters, including QRS-Tangle. Spatial QRS-Tangle
reﬂects the direction of propagation of disturbances of the
homogeneity ventricular depolarization process, thus the
combined measurement of the electrical activity of the
heart. This method is a sensitive and powerful tool for risk
stratiﬁcation of cardiac sudden death in general population
as well as selected group of patients [5]. However, the QRS-
Tangle of the special role is assigned to the prediction of
arrhythmic SCD [3, 5]. In studies on the homogeneity
of heart electrical activity abnormalities, was also assessed
a number of other parameters of the VCG. Particularly
promising are studies on the spatial orientation of the
vector T [6]. VCG parameter measurements are reliable,
reproducible and involve a small error [7]. Recent study has
showntheutilityofthemeasurementofspatialQRS-Tangle in
patients with end-stage renal disease [8].
2. Aim
This study was designed to assess the relationship between
aortic compliance and homogeneity of heart electrical
activity in dialysis patients. The key issue of this study was
the analysis of cardiac electric properties in dialysis patients.
3.MaterialandMethods
3.1. Clininical Characterization of Studied Groups. Study
group was consisted of 120 dialyzed patients divided to
two subgroups. First subgroup consisted of 57 patients (29
women and 28 men), 50,73 (±7,13) years old, who remained
on continuous ambulatory peritoneal dialysis (CAPD) of
mean duration 76,61 (±28,09) months. Patients were treated
with four 2000mL (2500mL in seven patients) enchanged
per day using Fresenius A.N.D.Y. Plus or stay safe (Fresenius
Medical Care, Bad Homburg, Germany), Baxter Twin Bag
(Baxter AG, Ljubljana, Slovenia), or Gambrosol (Gambro,
Lund, Sweden) systems. They have been suﬀered from ESRD
because of the following causes: glomerulonephritis—22
(38,6%), diabetes mellitus—12 (21,1%), chronic tubulo-
interstitial nephritis—4 (7,0%), obstructive nephropathy—
2 (3,5%), hypertonic nephropathy—1 (1,8%), analgetic
nephropathy—1 (1,8%), Alport syndrome—1 (1,8%), and
unknown/uncertain—14 (24,6%).
In the second subgroup were 73 patients (34 women
a n d3 7m e n )i na g eo f5 1 , 6( ±7,6) treated by haemodialysis
for mean time of 78,71 (±41,04) months. Haemodialyses
were performed three times a week using devices as Fre-
senius 4008B/S (Fresenius medical care, Bad Homburg,
Germany) and Gambro AK95S (Gambro, Lund, Sweden).
T h ec a u s e so fE S R Di nt h i ss u b g r o u pw e r ea sf o l l o w s :g l o m -
erulonephritis—32 (43,8%), diabetes mellitus—11 (15,1%),
chronic tubulo-interstitial nephritis—3 (4,1%), obstruc-
tive nephropathy—5 (6,8%), hypertonic nephropathy—3
(4,1%), polycystic kidney disease—4 (5,5%), and unknown/
uncertain—15 (20,5%).
Patients with known or potential factors that may
inﬂuence QRS-T values (with pacemakers, Wolﬀ-Parkinson-
White syndrome as well as right or left bundle branch block)
were excluded from the study.
3.2. Control Group. The control group comprised of 57
voluntaries (27 women and 30 men) in age of 51,9 (±7,1)
years of comparable to study group clinical characterization,
except that they did not suﬀer from ESRD. There were no
abnormalities detected by physical examination, ECG, chest
X-ray, and laboratory analysis.
3.3. Echocardiography. In all patient and control subjects,
standard transthoracic echocardiographic examination was
performed using 2,5–3,5MHz transducer (HP Sonos 7500)
bythecardiologist,whowasblindedtotheclinicaldataofthe
study subjects. All echocardiographic measurements were
done according to the guidelines of the American Society of
Echocardiography [9].
According to American Society of Echocardiography rec-
ommendations [9], the following two-dimensionally guided
M-mode echocardiographic parameters were recorded: in-
terventricularendsystolicseptumdiameter(IVSSd[cm]),in-
terventricular septum enddiastolic diameter (IVSDd [cm]),
posterior wall systolic diameter (PWSd [cm]), posterior wall
diastolic diameter (PWDd [cm]), left ventricle enddiastolic
diameter (LVEDd [cm]), left ventricle endsystolic diameter
(LVESd [cm]), aortic maximal diameter (Aomax [cm]), and
aorticminimaldiameter(Aomin [cm]).Consequently,several
standard indices were calculated according to American
Society of Echocardiography recom-mendations [9]s u c ha s
left ventricle stroke volume (SV [mL]), stroke index (SI [n]),
cardiac output (CO [L/min]), cardiac index (CI [L/min/
m2]), ejection fraction (EF [%]), and fractional shortening
of left ventricle (FS [%]).
Using previously measured parameters, the most impor-
tant indices for present study were calculated due to the
formulas:
(i) left ventricle mass (LVM [g]): LVM = 1,04 × [(IVSDd
+ PWDd + LVEDd)3] − 13,6g;
(ii) left ventricle mass index (LVMI [g/m2]): LVMI =
LVM/BSA;
(iii) endsystolic stress (ESS [103 dyn/cm2]): ESS = 0,334 ×
SBP × LVESd/PWSd × (1 + PWSd/LVESd);
(iv) midwall fractional shortening (mFS [n]): mFS =
[(LVEDd + PWSd/2 + IVSSd/2) − (LVESd + Hs/2)/
(LVEDd + PWSD/2 + IVSSd/2)] × 100; where Hs =
IVSSd + PWSd;The Scientiﬁc World Journal 3
Aomax
Aomin
Figure 1: The measurement of diameters needed for ASI calcula-
tion (aortic maximal diameter (Aomax), aortic minimal diameter
(Aomin)).
(v) ratio mFS/ESS [n];
(vi) aortic stiﬀness index (ASI [n]): ASI = log [(SBP/
DBP)/(Aomax− Aomin)]/Aomin (Figure 1).
Left ventricle hypertrophy was deﬁned by an LVMI of
>134g/m2 in man or >110g/m2 in women.
Moreover, pulsed Doppler, derived parameters were
measured such as maximal velocity of early diastolic trans-
mitral ﬂow (E [cm/s]), maximal velocity of late diastolic
transmitral ﬂow (A [cm/s]), isovolumetric relaxation time
(IVRT [ms]), maximal systolic velocity in pulmonary veins
(S [cm/s]), and maximal diastolic velocity in pulmonary
veins (D [cm/s]). Consequently, ratios of E/A and S/D were
calculated. Diastolic dysfunction was recognized accordingly
to recommendations of Canadian Cardiovascular Society
[8]. Patients with restrictive spectrum were not included to
this study.
The most important for this study echocardiographic
indices were ASI, presence of LVH, presence of diastolic
dysfunction, FS, and mFS. For ASI, the mean values were
calculated. Patients from both HD and CAPD groups were
divided and compared using calculated values of ASI as cut-
oﬀ values.
3.4. Vectorocardiography. Surface 12-lead resting ECGs were
recorded at the same hours of the day (between 09.00 and
11.00) in patients from CAPD group and two times among
hemodialysis subjects (before and just after haemodialysis).
According to previously described formulas [10, 11], the
following parameters concerning T vector was analyzed oﬀ-
line from the averaged QRST complexes via customized
software (Cardioperfect, version 1.1, CardioControl NV,
Rijswijk, The Netherlands, Figure 2):
(i) angulardiﬀerencebetweenthemaximumQRSvector
and maximum T vector (QRS-Tangle [◦]),
(ii) angle between the maximum T vector and the an axis
perpendicular to the horizontal plane (Telev [◦]),
(iii) angle between the projected maximum T vector on
the horizontal plane-XZ and the left extremity of the
X-axis (Taz [◦]).
3.5. Pressure and Laboratory Measuremennts. The systolic
(SBP) and diastolic (DBP) pressures were obtained using
electronic sphygmomanometer. Mean blood pressure (MBP)
was calculated by the formula: MBP = 1/3 SBP + 2/3 DBP.
Moreover, the mean heart rate calculated from the consecu-
tive 10 beats was recorded.
The following parameters were measured by automated
analyzers: haemoglobin, sodium, potassium, calcium, phos-
phorus, Ca × P score, creatinine, urea, total protein, albu-
min, CRP, total cholesterol, HDL-cholesterol, triglycerides,
and troponine. LDL-cholesterol was calculated using the
Friedewald equation: LDL (mg/dL) = total cholesterol −
HDL − (triglicerydes/5). Cardiac troponin T (cTnT) in plas-
ma was measured by the electrochemiluminescence immu-
noassay (Elecsys 2010 analyser, Roche Diagnostics Gmb,
Mannheim, Germany) with the detection limit of 0,01μg/L.
NT-proBNP in plasma was measured by the enzyme-
linked immunosorbent assay—ELISA method (Biomedica,
Bratislava, Slovakia) with the detection range of 0–640fmol/
mL. Asymmetric dimethylarginine (ADMA) was measured
by immunoenzymatic method—EIA (ALPCO Diagnostics,
Windham, New Hampshire, USA) with the detection range
between 0,05–3,0μmol/L and reference range for healthy
population of 0,4–0,75μmol/L.
The study protocol was approved by a university ethics
reviewboard.Theinvestigationconformswiththeprinciples
outlined in the Declaration of Helsinki.
4.StatisticalAnalysis
Statistical analysis was carried out on an IBM PC using of a
standard statistical package (SPSS for Windows Version 12.0;
SPSS INC, Chicago, Ill). Results were tested for normality.
Data were expressed as mean ± SD (parametrically dis-
tributed continuous variables) and percentage (categorical
variables). The statistical signiﬁcance of the diﬀerences
between HD patients, CAPD patients and control group
means were compared by unpaired Student’s t-test, the
Mann-Whitney test, or chi-square test with Yates correction.
Diﬀerences between values before and after hemodialysis
were determined using the paired Student’s t-test. Linear
regression analysis was performed by using the Pearson
test. Multiple stepwise regression analysis was performed to
estimatethepotential inﬂuenceofvariousfactorsontheASI.
The following independence parameters were entered into
the model: age, duration of dialysis, QRS-Tangle, Telev,a n d
Taz, ADMA, NT-proBNP haemoglobin, sodium, potassium,
calcium, phosphorus, Ca × P score, creatinine, urea, total
protein, albumin, CRP, total cholesterol, LDL-cholesterol,
HDL-cholesterol, triglycerides, and troponine. Probability
values of <0,05 were accepted as signiﬁcant.
5. Results
5.1. Baseline Comparison. Clinical characteristics and labo-
ratory measurements of the study population and control
group are listed in Table 1. The heart rate and SBD, MBP
were signiﬁcantly higher among CAPD and HD patients4 The Scientiﬁc World Journal
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compared to controls, whereas DBP did not diﬀer between
study subgroups and control group.
Comparison of ionic concentration has demonstrated
nondiﬀerence in sodium level among CAPD, HD, and con-
trol group, but concentration of potassium was signiﬁcantly
higher before haemodialysis and similar after haemodialysis
compared to control group. Calcium and phosphorus con-
centrations were signiﬁcantly lower in HD before hemodial-
ysis and among CAPD patients, and in that way, Ca × P
score was markedly higher in these patients than in controls.
Biochemical measurements characterizing renal function
wereobviouslyhigheramongdialysispatientsthanincontrol
group. The total protein concentration and albumin level
were markedly depressed in dialysis subjects compared to
normalsubjects.CRPwasseveral-foldhigheramongHDand
CAPDpatientsthanincontrols.Lipidogramhasshowncom-
parable concentration of total cholesterol, LDL-cholesterol,
whereas HDL-cholesterol was signiﬁcantly depressed in dial-
ysis patient. Opposite triglycerides were markedly elevated in
both HD and CAPD patients. ADMA concentrations both in
HDandCAPDpatientsweremarkedlyhigherthanincontrol
group. In dialysis patients, levels of cardiac markers such as
TroponinTandNT-proBNPwerehighregardlessofwhether
they were treated by hemodialysis or CAPD. Additionally,
NT-pro BNP has been decreased in HD after hemodialysis.
Baseline echocardiographic characteristics of the studied
patients and controls are shown in Table 2. All diameters
derived from a two-dimensionally guided M-mode echo-
cardiography were signiﬁcantly greater either in HD or
CAPD patients when compared to control group. Similarly,
parameters concerning left ventricle systolic and diastolic
functions were markedly diﬀer between both groups of
dialysis patients than in control group. SV and SI were
decreased among dialysis patients whereas CO and CI did
not diﬀer between them and controls. LVM and its index
were signiﬁcantly higher in HD and CAPD patients. Both
HD and CAPD patients exhibited signiﬁcantly greater aortic
stiﬀness expressed by higher value of ASI than in control
group. Parameters concerning left atrium were also greater
in dialysis patients than in control. The comparison between
HD and CAPD patients has been shown completely no
diﬀerence in all echocardiographic parameters.
The VCG data of the studied group are depicted in
Table 3. Both HD and CAPD patients diﬀered statistically
signiﬁcantlyfromcontrolsbyallofassessedVCGparameters.
Comparison between patients treated by hemodialysis andThe Scientiﬁc World Journal 5
Table 1: Pressure, heart rate, and biochemical measurements collected in studied patients (A—controls versus before HD, B—controls
versus after HD, B—controls versus CAPD; NA—not applicable).
Parameter Before HD After HD CAPD Controls ABC
Mean heart rate (beat/min) 74,40 (±10,81) 78,55 (±13,14) 75,1 (±5,89) 73,47 (±4,87) 0,402 0,001 0,201
Systolic blood pressure (mmHg) 139,4 (±22,1) 136,8 (±27,02) 141,8 (±20,71) 123,7 (±8,15) <0,001 <0,001 <0,001
Diastolic blood pressure (mmHg) 72,98 (±12,02) 74,21 (±15,27) 73,15 (±12,88) 74,15 (±9,09) 0,387 0,674 0,467
Mean blood pressure (mmHg) 95,07 (±14,28) 95,55 (±18,52) 95,96 (±13,89) 90,60 (±3,74) <0,001 <0,001 <0,001
Haemoglobin (g/dL) 11,98 (±1,46) 12,77 (±1,54) 11,52 (±1,26) 13,89 (±0,81) <0,001 <0,001 <0,001
Sodium (mmol/L) 138,5 (±2,5) 138,0 (±2,9) 137,9 (±3,1) 138,4 (±1,7) 0,583 0,236 0,482
Potassium (mmol/L) 5,698 (±0,735) 4,196 (±0,382) 4,42 (±0,56) 4,301 (±0,278) <0,001 0,112 0,509
Calcium (mmol/L) 2,259 (±0,190) 2,363 (±0,121) 2,262 (±0,186) 2,364 (±0,041) 0,007 0,716 0,015
Phosphorus (mmol/L) 1,991 (±0,541) 1,10 (±0,21) 1,62 (±0,49) 1,09 (±0,06) <0,001 0,003 0,269
Ca × P( m g 2/dL2) 55,86 (±14,64) 32,48 (±6,83) 48,51 (±10,62) 31,28 (±2,65) <0,001 0,401 0,001
Creatynine (μmol/L) 777,0 (±223,6) 303,2 (±122,9) 795,6 (±238,7) 81,33 (±9,79) <0,001 <0,001 <0,001
Urea (mmol/L) 24,39 (±7,22) 7,43 (±3,09) 21,46 (±7,03) 4,233 (±0,897) <0,001 <0,001 <0,001
Total protein (g/L) 68,3 (±0,52) NA 67,95 (±0,73) 72,01 (±0,28) <0,001 NA <0,001
Albumin (g/L) 3,935 (±0,356) NA 3,79 (±0,54) 4,636 (±0,204) <0,001 NA <0,001
CRP (mg/mL) 6,248 (±0,23) NA 7,41 (±0,82) 0,45 (±0,09) <0,001 NA <0,001
Total cholesterol (mg/dL) 189,7 (±43,75) NA 217,3 (±51,0) 190,5 (±22,32) 0,437 NA 0,269
LDL-cholesterol (mg/dL) 114,3 (±30,61) NA 129,0 (±21,7) 112,0 (±20,43) 0,504 NA 0,365
HDL-cholesterol (mg/dL) 41,51 (±16,19) NA 42,5 (±9,4) 56,7 (±11,24) <0,001 NA <0,001
Triglycerides (mg/dL) 170,8 (±74,89) NA 226,0 (±62,2) 109,1 (±38,9) <0,001 NA <0,001
Troponine (μg/L) 0,05 (±0,011) NA 0,058 (±0,013) 0,00 <0,001 NA <0,001
NT-proBNP (fmol/mL) 187,7 (±96,2) 165,8 (±91,9) 176,7 (±79,3) 22,71 (±17,23) <0,001 <0,001 <0,001
ADMA (μmol/L) 1,031 (±0,193) NA 0,991 (±0,176) 0,772 (±0,253) <0,001 NA <0,001
CAPD showed no signiﬁcant diﬀerence in QRS-Tangle, Telev,
and Taz values. Described diﬀerences were still present when
adjustment to left ventricle hypertrophy was done.
5.2.AssociationbetweenEchocardiographicandVectorocardio-
graphic Parameters. Of the numerous studied echocardio-
graphicvariables,onlyseveraloneshaveexhibitedsigniﬁcant
association with VCG parameters. In Table 4 are outlined
only signiﬁcant correlations, not signiﬁcant are mostly omit-
ted.
Among HD patients, the results of univariate lin-
ear regression analysis (Pearson’s test) showed particularly
strong correlations between LVMI versus QRS-Tangle, mFS/
ESS versus QRS-Tangle, and ASI versus QRS-Tangle.T h e r e
is also very tight association between LVMI versus Telev,
mFS versus Telev, and ASI versus Telev. Additionally, strong
correlation between ASI versus Taz is observed.
In CAPD patients are also very high correlations between
echocardiographically derived indices and VCG parameters.
As it is shown in Table 4, remarkably strong correlations are
between mFS/ESS versus QRS-Tangle and ASI versus QRS-
Tangle. Also strong associations between mFS versus Telev
and ASI versus Telev are exhibited. Moreover, there is strong
correlation of ASI versus Taz.
5.3. Cut-Oﬀ Value of ASI and Selected Laboratory and Vec-
torocardiographic Parameters. The calculated cut-oﬀ value
of ASI was 5,67 [n]. The comparison of VCG parameters
using ASI as cut-oﬀ values is shown in Table 5.I nTable 6
are presented selected laboratory parameters in patients of
below and above cut-oﬀ value of ASI in both HD and CAPD
groups.
5.4. Multiple Stepwise Regression Analysis. Multiple stepwise
regression analysis had showed that the ASI was indepen-
dently and markedly associated with QRS-Tangle, Telev, Taz,
ADMA, cTnT, CRP, Total chol, LDL-chol in both HD and
CAPD patients (Table 7).
6. Discussion
6.1. Vectorocardiographic Parameters. Ventricular repolariza-
tion abnormalities play an important role in the determi-
nation of arrhythmia and sudden cardiac death. Because
the standard ECG has well-known limitations, three-
dimensional vectorocardigraphy has emerged as a possible
tool. Several recent studies have demonstrated that increased
value of vectorocardiographic parameters, particularly the
spatial QRS-Tangle, is strong and independent predictor
of arrhythmic death. It is stronger than any of the clas-
sical cardiovascular risk factors and vectorcardiographic
parameters provide additional value to standard ECG risk
indicators in predicting fatal cardiac events [12]. Ventricular
reporarization may be inﬂuenced by many factors such as6 The Scientiﬁc World Journal
Table 2: Echocardiographic data (A—controls versus CAPD, B—controls versus HD, C—HD versus CAPD).
Parameter HD CAPD Controls AB C
Diameters of the heart
LVEDd (cm) 5,14 (±0,59) 5,05 (±0,47) 4,62 (±0,44) <0,001 <0,001 0,467
LVESd (cm) 3,23 (±0,54) 3,35 (±0,49) 2,91 (±0,36) <0,001 <0,001 0,502
PWDd (cm) 1,24 (±0,24) 1,23 (±0,28) 0,91 (±0,05) <0,001 <0,001 0,672
PWSd (cm) 1,60 (±0,23) 1,53 (±0,31) 1,29 (±0,06) <0,001 <0,001 0,391
IVSDd (cm) 1,44 (±0,24) 1,37 (±0,21) 0,94 (±0,06) <0,001 <0,001 0,365
IVSSd (cm) 1,67 (±0,28) 1,59 (±0,22) 1,18 (±0,07) <0,001 <0,001 0,401
Parameters of LV mass
LVM (g) 253,9 (±92,53) 234,6 (±76,0) 154,6 (±32,6) <0,001 <0,001 0,326
LVMI (g/m2) 146,5 (±45,18) 139,0 (±32,0) 97,14 (±26,35) <0,001 <0,001 0,511
LVH (%) 64,8 61,4 0
Parameters of heart stroke
SV (mL) 70,39 (±15,34) 72,02 (±12,66) 79,46 (±13,03) 0,012 0,009 0,216
SI (mL/beat/m2) 42,08 (±11,19) 42,45 (±10,23) 45,93 (±4,22) 0,002 0,001 0,560
CO (L/min) 5,49 (±0,81) 5,43 (±0,88) 5,73 (±0,49) 0,089 0,106 0,452
CI (L/min/m2)3 , 2 4 ( ±0,53) 3,23 (±0,54) 3,31 (±0,32) 0,123 0,126 0,485
Parameters of systolic function
EF (%) 58,91 (±6,21) 58,33 (±7,02) 65,52 (±3,87) <0,001 <0,001 0,753
FS (%) 31,54 (±5,83) 29,93 (±5,26) 38,9 (±4,302) <0,001 <0,001 0,563
mFS (%) 15,34 (±3,26) 15,89 (±2,92) 20,12 (±2,87) <0,001 <0,001 0,672
mFS/ESS (n) 0,186 (±0,056) 0,191 (±0,042) 0,218 (±0,043) 0,004 0,002 0,389
Parameters of diastolic function
E/A (n) 0,979 (±0,256) 1,012 (±0,238) 1,371 (±0,135) <0,001 <0,001 0,486
IVRT (ms) 109,1 (±22,73) 111,4 (±19,65) 76,53 (±14,04) <0,001 <0,001 0,509
DT (ms) 229,9 (±45,12) 223,7 (±38,5) 179,3 (±27,41) 0,002 0,001 0,381
S/D (n) 1,49 (±0,268) 1,42 (±0,302) 1,22 (±0,181) 0,001 <0,001 0,638
Relaxation abnormalities (%) 43,66 49,1 1,75
Parameters of aorta
ASI (n) 5,51 (±1,32) 5,83 (±1,41) 3,07 (±1,09) <0,001 <0,001 0,761
Table 3: The VCG parameters (A—controls versus before HD, B—controls versus after HD, C—controls versus CAPD, D—CAPD versus
before HD, E—before HD versus after HD).
Parameter Before HD After HD CAPD Controls ABCDE
VCG parameters
nonadjusted to LVMI
QRS-Tangle (◦) 30,18 (±9,84) 41,09 (±11,74) 34,79 (±11,79) 13,65 (±7,23) <0,001 <0,001 <0,001 0,213 <0,001
Telev (◦) 71,86 (±11,06) 77,36 (±12,62) 72,67 (±11,18) 44,08 (±9,13) 0,007 <0,001 0,006 0,623 0,017
Taz (◦) 37,5 (±22,54) 44,48 (±20,34) 39,23 (±19,87) 21,31 (±18,91) 0,009 <0,001 0,007 0,398 0,039
VCG parameters
adjusted to LVMI
QRS-Tangle/LVMI
(◦/g/m2) 0,207 (±0,095) 0,281 (±0,119) 0,251 (±0,112) 0,141 (±0,082) 0,006 <0,001 <0,001 NA NA
Telev/LVMI (◦/g/m2) 0,492 (±0,072) 0,53 (±0,093) 0,523 (±0,091) 0,454 (±0,081) 0,041 0,009 0,013 NA NA
Taz/LVMI (◦/g/m2) 0,257 (±0,079) 0,305 (±0,085) 0,282 (±0,061) 0,219 (±0,062) 0,021 0,001 0,001 NA NA
left ventricle hypertrophy and myocardial ischemia, which
is manifested by increasing vectorocardiographic parameter
values [6]. Our present study demonstrates that spatial QRS-
Tangle, Telev,a n dTaz are signiﬁcantly higher among patients
with end-stage renal disease despite patients were treated
by hemodialysis or staying on continuous ambulatory peri-
toneal dialysis. As we previously demonstrated, QRS-Tangle is
markedly higher in CAPD patients than in control ones [10].
The present analysis demonstrates that other vectorocardio-
graphic parameters are also higher in patients with end-stageThe Scientiﬁc World Journal 7
Table 4: Relationship of VCG parameters and selected echocardiographic parameters (in HD group VCG parameters recorded after dialysis
were analysed).
QRS-Tangle versus echocardiographic parameters
Parameter CAPD patients HD patients
RPr P
LVEDd 0,274 0,043
PWSd 0,285 0,036 0,275 0,021
PWDd 0,287 0,032 0,296 0,012
IVSSd 0,265 0,027
IVSDd 0,275 0,021
LVM 0,311 0,021 0,302 0,011
LVMI 0,327 0,013 0,369 0,002
mFS/ESS 0,397 0,002 0,325 0,006
ASI 0,452 <0,001 0,429 <0,001
Telev versus echocardiographic parameters
PWSd 0,274 0,042 0,270 0,024
PWDd 0,295 0,026 0,265 0,027
IVSSd 0,278 0,020
IVSDd 0,259 0,031
LVMI 0,308 0,021 0,394 0,001
mFS 0,393 0,001 0,410 0,002
ASI 0,417 <0,001 0,432 <0,001
Taz versus echocardiographic parameters
PWSd 0,279 0,032 0,273 0,023
PWDd 0,274 0,041 0,266 0,027
IVSSd 0,280 0,019
IVSDd 0,261 0,030
LVMI 0,269 0,047 0,263 0,029
ASI 0,390 0,001 0,387 0,001
Table 5: Aortic stiﬀness index cut-oﬀ value of >5,67 versus VCG parameters.
Parameter HD group CAPD group
ASI < 5,67 ASI > 5,67 P ASI < 5,67 ASI > 5,67 P
QRS-Tangle (◦) 43,53 (±9,62) 38,19 (±9,61) 0,008 37,21 (±9,91) 32,12 (±7,19) 0,001
Telev (◦) 65,72 (±8,93) 59,94 (±9,22) <0,001 63,12 (±9,03) 55,85 (±10,1) <0,001
Taz (◦) 44,65 (±10,04) 43,98 (±9,52) NS 39,56 (±8,67) 39,18 (±9,71) NS
Table 6: The comparison of calculated cut-oﬀ value of ASI o laboratory parameters.
Parameter HD group CAPD group
ASI > cut-oﬀ value ASI < cut-oﬀ value P ASI > cut-oﬀ value ASI < cut-oﬀ value P
ADMA 1,134 (±0,201) 0,881 (±0,169) 0,002 1,104 (±0,198) 0,874 (±0,189) 0,012
cTnT 0,068 (±0,016) 0,043 (±0,09) 0,001 0,066 (±0,019) 0,045 (±0,01) 0,002
CRP 6,92 (±0,51) 5,57 (±0,21) 0,007 8,23 (±0,98) 6,62 (±0,72) 0,001
Total chol 229,4 (±46,9) 162,4 (±40,2) 0,01 232,6 (±55,1) 202,5 (±47,6) 0,05
LDL-chol 128,2 (±33,5) 101,1 (±27,3) 0,02 144,6 (±32,1) 115,7 (±20,8) 0,04
NT-proBNP 195,8 (±101,5) 172,9 (±92,8) 0,03 188,5 (±82,5) 168,4 (±75,4) 0,04
Creatynine 792,0 (±229,9) 762,4 (±218,8) 0,18 806,6 (±241,6) 782,9 (±222,1) 0,21
Ca × P 56,34 (±15,14) 54,41 (±13,81) 0,32 50,21 (±10,88) 47,93 (±9,63) 0,378 The Scientiﬁc World Journal
Table 7: Factors inﬂuencing ASI estimated by multivariate stepwise regression analysis.
HD group CAPD group
Dependent
variable
Independent
variables B Standard
error βP Independent
variables B Standard
error βP
ASI
QRS-Tangle 1,241 0,112 0,302 0,007 QRS-Tangle 1,152 0,132 0,2293 0,012
Telev 0,617 0,178 0,367 0,008 Telev 2,765 0,452 0,362 0,021
Taz 9,743 3,521 0,523 0,032 Taz 10,348 3,8745 0,564 0,048
ADMA 50,323 16,561 0,409 0,006 ADMA 36,865 12,879 0,422 0,040
cTnT 121,5 34,66 0,443 <0,001 cTnT 113,7 42,35 0,311 0,001
CRP 4,923 1,832 0,281 0,002 CRP 5,023 1,792 0,421 0,043
Total chol 0,805 0,237 0,340 0,003 Total chol 0,657 0,193 0,342 0,046
LDL-chol 1,427 0,428 0,329 0,004 LDL-chol 1,283 0,384 0,382 0,009
renal disease. To our knowledge, this is the ﬁrst study to
assess the vectorocardiographic parameters in hemodialysis
patients. As it has shown in results, there is no signiﬁcant
diﬀerence between values of spatial QRS-Tangle, Telev,a n dTaz
in CAPD patients and hemodialysis subject. Opposite he-
modialysis markedly inﬂuenced ventricular repolarisation
which reﬂects in increasing of all vectorocardiographic pa-
rameters recorded after hemodialysis. In end-stage renal
disease,increaseddispersionofventricularrepolarizationhas
been implicated in the genesis of ventricular arrhythmias.
Several data-processing methods have been proposed to
detect T-wave pattern abnormalities. Recently, other novel
descriptors of T-wave morphology have been suggested as
measures of repolarisation heterogeneity and adverse prog-
nosis in uremic population. Study performed by Lin et al.
[13] demonstrated that the heterogeneity of ventricular
repolarization measured by calculating relative T-wave
residuum (TWR) is an independent noninvasive predictor
for cardiovascular death in patients initiating haemodialysis.
In this study, classical electrocardiographic indices of ven-
tricular repolarisation such as corrected QT, corrected QT
dispersion, and other T-wave morphology descriptors had
a poor correlation of relative TWR. The authors concluded
that the nondipolar content of the ECG provides indepen-
dent information regarding ventricular repolarisation. In
that way demonstrated in our study, signiﬁcant increase of
spatialvectorocardiographicparametersconcerningT vector
may also better reﬂect increased repolarisation heterogeneity
than dipolar approach in dialysis patients.
6.2. LVH and Vectorocardiographic Parameters. Left ventric-
ular hypertrophy (LVH) is common ﬁnding in patients with
end-stage renal disease. Also in the present study, among
hemodialysis patients 64,8% had left ventricle hypertrophy,
and in CAPD group 61,4% were hypertrophic. Left ven-
tricle hypertrophy has been recognized as an important
risk factor for nonfatal and fatal cardiovascular events
including sudden cardiac death due to severe ventricular
arrhythmias. According to experimental studies, myocardial
hypertrophy is associated with altered electrophysiological
properties including prolonged repolarisation. It has also
reduced repolarisation reserve essentially meaning reduced
compensatory mechanism for counteracting perturbations
of repolarisation [14].
The present study demonstrates that the QRS-Tangle is
related to the left ventricle wall thickness. After adjustment
for LVMI, the all analyzed parameters as QRS-Tangle, Telev,
and Taz strongly correlated to LVMI. Additionally, compared
with subgroups without hypertrophy, patients with hyper-
trophy had signiﬁcantly increased QRS-Tangle, Telev,a n dTaz
values in both dialysis as well as CAPD group. This is also the
ﬁrst study to assess the inﬂuence of left ventricle hypertrophy
on vectorocardiographic parameters in patients with end-
stage renal disease. Left ventricle hypertrophy inﬂuencing
QRS-Tangle has been the subject of previous reports in several
clinical setting other than our dialysis study. In the study
performed by Ishizawa et al. [15], widening of the spatial
QRS-Tangle was observed only in the subjects with LVH. In
cases of mild or moderate LVH, normal spatial QRS-Tangle
was observed. It was thus concluded that the magnitude
of the spatial ventricular gradient increases proportionally
to an increase in total left ventricular muscle volume in
hypertrophy. In patients without overt coronary artery dis-
ease, the increased spatial variation in T-wave morphology
in patients with LVH was found as the result from a
signiﬁcant relationship between the spatial vectorocardio-
graphic parameters and the left ventricle wall thickness [16].
Additionally, in patients with severe coronary artery disease,
it has been shown that in presence of left ventricle hypertro-
phy, ischemia induces aggravation of baseline repolarisation
abnormalities as evaluated bywider spatial QRS-Tangle values
[6].
Myocardial hypertrophy can lead to prolonged repolari-
sation due to several diﬀerent mechanisms such as impaired
coronary vasodilataor reserve, decreased capillary density,
and increased diﬀusion distance, owing to increased myocar-
dial cell diameter without proportional proliferation of
capillary vessels [6]. Some metabolic conditions should be
also taken into account: decreased high-energy phosphate
content and impaired fatty acid oxidation leading to increase
dependence on glucose metabolism and reduced myocar-
dial transport into the cell [17]. In dialysis patients, theThe Scientiﬁc World Journal 9
repolarisation abnormalities are most consistently linked to
left ventricle hypertrophy although changes of phosphorus,
calcium, and potassium levels plus extracellular body water
values might contribute in ventricular inhomogeneities [18].
6.3. Left Ventricle Function and Vectorocardiography. EF and
F Si nh e m o d i a l y s i sa sw e l la si nC A P Dg r o u pw e r em a r k e d l y
lower than in controls but there were no correlations
between these parameters of systolic function and none
of vectorocardiographic parameters. This is probably stems
from the fact that these parameters had lower values than
in control group but still were within in the range of
values considered as appropriate. In the research consider-
ing predictive value of vectorocardiographic parameters in
congestive cardiomyopathy, patients with QRS-Tangle value
< 90◦ had signiﬁcantly lower EF than subjects with QRS-
Tangle > 90◦ [19]. The diﬀerence was only 2% but average
EF in the group was close to 22%. Moreover, changes
in EF were associated with changes in QRS-Tangle during
followup [19]. In the study presented by Friedman [20],
enrolledpatientswithgoodsystolicfunction(meanEF65%),
spatial QRS-Tangle reﬂected as total cosine (TCRT) was not
related to EF and FS. In our study, more sensitive index of
left ventricle contractility, which is mFS/ESS, was strongly
correlated with QRS-Tangle. The study in diabetic patients
showed a strong and independent relationship between the
QRS-Tangle and total left ventricle performance assessed by
the Tei index, because Tei index is an echocardiographic
index that combines both left ventricle systolic and diastolic
function [21].
Patients with end-stage renal disease often suﬀer from
uremic cardiomyopathy which is characterized mainly by
diastolic dysfunction. In our study, also the impairment of
left ventricle diastolic function was noted in dialysis patients
despite of dialysis method used. The deterioration of left
ventricle diastolic function was manifested by low A/E ratio,
prolongation of early diastolic ﬁlling deceleration, increasing
of IVRT, and higher values of S/D ratio. The present study
demonstratesthatQRS-Tangle andTelev arerelatedtodiastolic
performance of left ventricle. The study demonstrated by
Friedman [20] has shown that the dissociation between nor-
mal pattern of depolarization and repolarization, reﬂected
by increasingly more negative total cosine of QRS-Tangle,
aﬀected left ventricle ﬁlling. Maximal ejection ﬂow velocity
and atrial ejection time and therefore, atrial velocity time
integral were negatively related to TCRT. Although maximal
early transmitral ﬂow velocity and isovolumic relaxation
time did not correlate with TCRT, E-wave deceleration time
related inversely to TCRT and E/A ratio directly to TCRT,
reﬂecting the negative correlation of A with TCRT.
6.4. ASI and Vetorocardiography. We evaluated that aortic
wall stiﬀness index was signiﬁcantly higher in patients
with end-stage renal disease than in subjects without renal
dysfunction. It is well known that aortic elastic properties
are aﬀected by the risk factors for atherosclerosis. The
coexistence of atherosclerosis and end-stage renal failure
suggests there is a link between these two diseases [22].
Atherosclerosis is regarded as a combination of two features
of two separate diseases: atherosis and sclerosis. Sclerosis
component depends on deterioration of aortic elastic prop-
erties and is called aortic stiﬀness. Calcium overload which
is characteristic feature for end-stage renal disease patients
is associated with aortic stiﬀening. Vascular calciﬁcation is
detected either in the tunica intima or in the tunica media.
Calciﬁcation in the intima is characteristic of most stages of
atherosclerosis. Medial calciﬁcation is particularly common
in patients with end-stage renal disease and may occur
independently of atherosclerosis. Medial wall calciﬁcation
increases vascular stiﬀness and reduces arterial compliance.
Our data demonstrate that patients with end-stage renal
disease have higher values of all measured vectorocardio-
graphic parameters. To the best of our knowledge, there
are no data in the literature on aortic stiﬀness inﬂuence on
spatial QRS-Tangle in patients with end-stage renal disease.
Aortic stiﬀness is regarded as an independent predictor
of all-cause and cardiovascular mortality in hypertensive
patients [1]. Blacher and coworkers [2] have found that
aortic stiﬀness in patients who require haemodialysis was a
major predictor of all-cause and cardiovascular mortality.
We can only speculate about the mechanism linking aortic
stiﬀness with left ventricle repolarisation abnormalities. Loss
of aortic wall compliance causes pressure elevation and
abnormal pressure pattern that increases the afterload of
the left ventricle. The result is development of left ventricle
hypertrophy another predictor of death form cardiovascular
disease. Another explanation is higher prevalence of coro-
nary atherosclerotic changes in patients with aortic stiﬀness
[23]. Repolarisation abnormalities may appear due to dias-
tolic dysfunction. The reason for repolarisation disturbances
may be also left ventricle diastolic dysfunction coexistent
with deterioration of elastic properties of aorta, what was
observed among diabetic and hypertensive patients [24].
7. Conclusions
(1) ASI and VCG indices are higher in both HD and
CAPD patients.
(2) Correlation between ASI and VCG parameters may
reﬂect unfavourable inﬂuence of poor aortic compli-
ance on the electrical activity of the heart in dialyzed
patients.
(3) Hypertrophy aggravates repolarization disturbances
in hemodialyzed patients.
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